SC Explains When Shares Received After Company Amalgamation are Taxable as Business Income  ||  SC: Excavators, Dumpers Etc Used Within Factories aren’t Motor Vehicles For Road Tax Purposes  ||  SC: Complaints Alleging Fraud under Companies Act Can Be Filed Only By SFIO, Not By Private Parties  ||  SC: Preventive Detention Cannot Override Bail and Requires Proof of a Threat to Public Order  ||  Supreme Court: Multiple Complaints Are Valid For Dishonour of Several Cheques in One Transaction  ||  SC: Bail Should Not be Refused Mechanically Nor Granted Based on Irrelevant Considerations  ||  Gujarat HC: Motor Accident Compensation Doesn’t Cover Medical Expenses Paid by Charity  ||  HP High Court: Panchayati Raj Elections Cannot Be Postponed Beyond Five-Year Term  ||  Ker HC: Victim Cannot File Second Appeal Seeking Special Leave Against Acquittal Under S.419(4) BNSS  ||  Delhi HC: Right to Higher or Professional Education is Fundamental and Cannot be Curtailed Lightly    

SEBI Imposes Rs. 22 Crore fine on Aurobindo Pharma for Insider Trading - (24 Sep 2019)

CAPITAL MARKET

Securities and Exchange Board of India has imposed a fine of Rs. 22.7 crore on Aurobindo Pharma Ltd., its promoters and related entities for insider trading between July, 2008 to March, 2009.

Tags : SECURITIES AND EXCHANGE BOARD OF INDIA   AUROBINDO PHARMA LTD.  SEBI  

Share :        

Disclaimer | Copyright 2026 - All Rights Reserved